Literature DB >> 16857002

Successful unrelated mismatched cord blood transplantation in a child with malignant infantile osteopetrosis.

Tang-Her Jaing1, Jia-Woei Hou, Shih-Hsiang Chen, I-Anne Huang, Chao-Jan Wang, Wei-I Lee.   

Abstract

Allogeneic hematopoietic stem cell transplantation represents the only curative option for malignant infantile osteopetrosis (MIOP), a rare disease of infants and young children, characterized by excessive accumulation of mineralized bone and abnormal hematopoiesis. We report a case of successful engraftment and stable full-donor chimerism in a patient with MIOP who underwent unrelated donor cord blood transplantation (CBT). The donor was 2-loci human leukocyte antigen (HLA)-mismatch. After a conditioning regimen based on the combination of busulfan, cyclophosphamide, total body irradiation, and antithymocyte globulin, the patient received a dose of 3.85 x 10(7)/kg of nucleated cells. Neutrophil and platelet engraftment had been achieved by day +33 and +82, respectively, and the patient was discharged home on day +89. A successful engraftment of donor hematopoiesis was demonstrated and the child experienced grade II acute graft-vs.-host disease (GVHD) involving the skin only. A remarkable but non-progressive decrease in lumbar spine bone mineral density was observed in the first nine months post-transplant. This case suggests that unrelated donor CBT may be a feasible option in case of unavailability of a fully HLA-matched related or unrelated donor.

Entities:  

Mesh:

Year:  2006        PMID: 16857002     DOI: 10.1111/j.1399-3046.2006.00537.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  4 in total

1.  Novel mutation of TCIRG1 and clinical pictures of two infantile malignant osteopetrosis patients.

Authors:  Ping Yuan; Zhihui Yue; Liangzhong Sun; Weijun Huang; Bin Hu; Zhiyun Yang; Yuelin Hu; Hua Xiao; Hui Shi; Qing Zhou; Yiming Wang
Journal:  J Bone Miner Metab       Date:  2010-11-02       Impact factor: 2.626

2.  Prognostic potential of precise molecular diagnosis of Autosomal Recessive Osteopetrosis with respect to the outcome of bone marrow transplantation.

Authors:  Anna Villa; Alessandra Pangrazio; Elena Caldana; Matteo Guerrini; Paolo Vezzoni; Annalisa Frattini; Cristina Sobacchi
Journal:  Cytotechnology       Date:  2008-09-30       Impact factor: 2.058

Review 3.  Cord blood in regenerative medicine: do we need immune suppression?

Authors:  Neil H Riordan; Kyle Chan; Annette M Marleau; Thomas E Ichim
Journal:  J Transl Med       Date:  2007-01-30       Impact factor: 5.531

Review 4.  Assessing the Efficacy of Alkylating Agent Regimens in the Treatment of Infantile Malignant Osteopetrosis: Cyclophosphamide, Busulfan, or Thiotepa.

Authors:  Himanshu Wagh; Amber Arif; Akshay J Reddy; Ethan Tabaie; Aditya Shekhar; Mildred Min; Neel Nawathey; Mark Bachir; Hetal Brahmbhatt
Journal:  Cureus       Date:  2022-07-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.